Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
2020-02-14 1:18 pm Purchase | 13G | PTC THERAPEUTICS INC. PTCT | RTW INVESTMENTS LP | 3,832,480 6.22% | 1,910,134 (+99.36%) | View |
2020-02-12 08:09 am Purchase | 13G | PTC THERAPEUTICS INC. PTCT | VANGUARD GROUP INC | 5,441,640 8.82% | 845,535 (+18.40%) | View |
2020-02-10 07:32 am Purchase | 13G | PTC THERAPEUTICS INC. PTCT | BlackRock Inc. BLK | 4,914,593 8% | 1,207,352 (+32.57%) | View |
2020-02-07 11:28 am Sale | 13G | PTC THERAPEUTICS INC. PTCT | FMR LLC | 2,448,142 3.97% | -375,673 (-13.30%) | View |
2020-02-05 3:07 pm Purchase | 13G | PTC THERAPEUTICS INC. PTCT | FRANKLIN RESOURCES INC BEN | 5,470,308 8.7% | 2,256,015 (+70.19%) | View |
2020-01-31 4:04 pm Purchase | 13D | ClearPoint Neuro Inc. CLPT | PTC THERAPEUTICS INC. PTCT | 2,956,990 17.27% | 1,666,667 (+129.17%) | View |
2019-05-24 4:15 pm Purchase | 13D | ClearPoint Neuro Inc. CLPT | PTC THERAPEUTICS INC. PTCT | 1,290,323 9.56% | 1,290,323 (New Position) | View |
2019-05-21 4:10 pm Purchase | 13G | PTC THERAPEUTICS INC. PTCT | Point72 Asset Management L.P. | 2,931,236 5% | 2,931,236 (New Position) | View |